Latest Breaking News On - Segment net sales increased - Page 1 : comparemela.com

First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123.4 Million; Adjusted EBITDA of $45.8 Million First-Quarter 2021 Orphan Segment Net Sales Increased

United statesViela bioRuth venningGeoff curtisTim walbertTina venturaNeuroimmunology neuroinflammationRay gordonDevelopment pipelineReddy laboratoryViela bio incSubcutaneous administrationKey clinical development programsCompanies to workResearch in multiple sclerosisAmerican committee for treatment